Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): A targeted oncoprotein strikes back
N. von Bubnoff, C. Peschel, J. Duyster*
*Corresponding author for this work
99
Link opens in a new tab
Citations
(Scopus)